e-learning
resources
Virtual 2020
Pre-Congress Content
Physical activity and chronic lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
"Can do" versus "do do" in patients with asthma
S. Janssen (Leiden, Netherlands), M. Spruit (Horn, Netherlands), J. Antons (Nijmegen, Netherlands), R. Djamin (Breda, Netherlands), J. Abbink (Leiden, Netherlands), H. Van Helvoort (Nijmegen, Netherlands), A. Van 'T Hul (Nijmegen, Netherlands)
Source:
Virtual Congress 2020 – Physical activity and chronic lung disease
Session:
Physical activity and chronic lung disease
Session type:
E-poster session
Number:
249
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Janssen (Leiden, Netherlands), M. Spruit (Horn, Netherlands), J. Antons (Nijmegen, Netherlands), R. Djamin (Breda, Netherlands), J. Abbink (Leiden, Netherlands), H. Van Helvoort (Nijmegen, Netherlands), A. Van 'T Hul (Nijmegen, Netherlands). "Can do" versus "do do" in patients with asthma. 249
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Can do’ versus ‘do do’: a novel concept in patients with COPD
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018
What do patients with COPD need to know?
Source: Eur Respir J 2003; 22: Suppl. 45, 168s
Year: 2003
What do patients want in an asthma app?
Source: International Congress 2019 – Person-centred approaches to COPD and asthma care
Year: 2019
Who to treat/who not to treat: the "non group I" PH patients
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Is the question ² how is your asthma doing? ² sufficient to assess asthma control in primary care?
Source: Eur Respir J 2004; 24: Suppl. 48, 269s
Year: 2004
Why isn't his asthma getting better Doctor?
Source: ERS Live 2009
Year: 2009
Why don't patients follow the rules? Understanding the motivation behind behavioural change
Source: Annual Congress 2013 –PG8 How to encourage compliance with therapy
Year: 2013
What does healthy people know about asthma?
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011
"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
New guidelines for chronic cough: what we know and what we don’t know
Source: International Congress 2019 – New clinical practice guidelines for chronic cough
Year: 2019
What do patients expect from ERN-LUNG?
Source: International Congress 2018 – Rare lung diseases
Year: 2018
Phenotyping SDB: why doesn't everyone get sick?
Source: International Congress 2014 – Current controversies in sleep-disordered breathing (SDB)
Year: 2014
Can " Beta-blockers" be useful to treat asthma?
Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD
Year: 2009
Clustering in asthma: why, how and for how long?
Source: Eur Respir J 2013; 41: 1247-1248
Year: 2013
Neutrophilic inflammation: "Don't you go to pieces on me!"
Source: Eur Respir J 2006; 28: 257-258
Year: 2006
One airway one disease from a different perspective – eyes cant see what the mind doesn’t know
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Can we consider the "frequent exacerbator" a reliable COPD phenotype?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
The 'surprise question' in patients surviving severe COPD exacerbation.
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept